We are live on ! Find out more
GI

GAMMA Investing Portfolio holdings

AUM $2.69B
1-Year Est. Return 42.78%
This Fund
S&P 500
This Quarter Est. Return
+24.07%
1 Year Est. Return
+42.78%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.69B
AUM Growth
+$545M
Cap. Flow
+$236M
Cap. Flow %
8.79%
Top 10 Hldgs %
25.36%
Holding
4,296
New
186
Increased
2,357
Reduced
1,127
Closed
124

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$12.5M
2
NVDA icon
NVIDIA
NVDA
+$12M
3
IEMG icon
iShares Core MSCI Emerging Markets ETF
IEMG
+$8.7M
4
AMZN icon
Amazon
AMZN
+$8M
5
MSFT icon
Microsoft
MSFT
+$7.83M

Top Sells

Rank Stock Value
1
MCHI icon
iShares MSCI China ETF
MCHI
+$1.41M
2
CTRA
Coterra Energy
CTRA
+$1.22M
3
HOLX
Hologic
HOLX
+$1.19M
4
HON icon
Honeywell
HON
+$1.12M
5
NFLX icon
Netflix
NFLX
+$1M

Sector Composition

Rank Sector Weight
1 Technology 29.94%
2 Financials 11.36%
3 Industrials 9.29%
4 Healthcare 8.12%
5 Consumer Discretionary 7.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ESOA icon
3326
Energy Services of America
ESOA
$297M
$1.37K ﹤0.01%
71
BALY icon
3327
Bally's
BALY
$672M
$1.37K ﹤0.01%
100
-159
-61% -$2.03K
BSCU icon
3328
Invesco BulletShares 2030 Corporate Bond ETF
BSCU
$2.63B
$1.36K ﹤0.01%
82
+49
+148% +$818
KWY
3329
Kingsway Corp
KWY
$249M
$1.36K ﹤0.01%
131
GLSI icon
3330
Greenwich LifeSciences
GLSI
$191M
$1.36K ﹤0.01%
58
+31
+115% +$754
AOMR
3331
Angel Oak Mortgage REIT
AOMR
$219M
$1.35K ﹤0.01%
149
+82
+122% +$706
INMB icon
3332
INmune Bio
INMB
$43.1M
$1.35K ﹤0.01%
829
-775
-48% -$1.07K
MVST icon
3333
Microvast
MVST
$267M
$1.34K ﹤0.01%
1,148
+399
+53% +$615
RYAM icon
3334
Rayonier Advanced Materials
RYAM
$565M
$1.34K ﹤0.01%
170
-56
-25% -$508
BSVN icon
3335
Bank7 Corp
BSVN
$471M
$1.32K ﹤0.01%
27
NTR icon
3336
Nutrien
NTR
$32.7B
$1.32K ﹤0.01%
21
PZA icon
3337
Invesco National AMT-Free Municipal Bond ETF
PZA
$4.19B
$1.32K ﹤0.01%
56
IVOO icon
3338
Vanguard S&P Mid-Cap 400 ETF
IVOO
$3.73B
$1.3K ﹤0.01%
+10
New +$1.24K
PEBK icon
3339
Peoples Bancorp of North Carolina
PEBK
$229M
$1.29K ﹤0.01%
30
QTRX icon
3340
Quanterix
QTRX
$173M
$1.29K ﹤0.01%
299
-391
-57% -$1.27K
FWRG icon
3341
First Watch Restaurant Group
FWRG
$747M
$1.29K ﹤0.01%
+100
New +$1.17K
BARK icon
3342
BARK
BARK
$74.8M
$1.29K ﹤0.01%
129
+119
+1,190% +$1.12K
RZLV
3343
Rezolve AI
RZLV
$893M
$1.27K ﹤0.01%
404
-127
-24% -$334
AQST icon
3344
Aquestive Therapeutics
AQST
$462M
$1.24K ﹤0.01%
299
CHRS icon
3345
Coherus Oncology
CHRS
$217M
$1.24K ﹤0.01%
885
-325
-27% -$531
VFLO icon
3346
VictoryShares Free Cash Flow ETF
VFLO
$8.44B
$1.24K ﹤0.01%
27
IMO icon
3347
Imperial Oil
IMO
$62.1B
$1.23K ﹤0.01%
11
KEEL
3348
Keel Infrastructure Corp
KEEL
$2.57B
$1.23K ﹤0.01%
+214
New +$919
EVGO icon
3349
EVgo
EVGO
$200M
$1.22K ﹤0.01%
637
OMER icon
3350
Omeros
OMER
$709M
$1.22K ﹤0.01%
128

Similar funds

GAMMA Investing's Q2 2026 Portfolio in Review

As of Q2 2026, GAMMA Investing held 4,296 positions worth $2.69B, up 25% from $2.14B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

GAMMA Investing deployed $236M of net new capital in Q2 2026, opening 186 new positions and adding to 2,357 existing holdings. Its largest new stake was Honeywell Aerospace: 5,619 shares worth $1.24M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 26% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was iShares MSCI China ETF, an estimated $1.41M trimmed.

  • GAMMA Investing's largest Q2 2026 buy was Honeywell Aerospace: 5,619 shares worth $1.24M.
  • GAMMA Investing added most to Apple in Q2 2026, an estimated $12.5M increase.
  • GAMMA Investing's biggest Q2 2026 reduction was iShares MSCI China ETF, cutting an estimated $1.41M.
  • GAMMA Investing fully exited Coterra Energy in Q2 2026, selling an estimated $1.22M.
  • GAMMA Investing's ten largest holdings make up 25% of its $2.69B portfolio in Q2 2026.
  • GAMMA Investing opened 186 new positions and closed 124 in Q2 2026.
  • GAMMA Investing's portfolio value rose 25% quarter-over-quarter to $2.69B.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.